tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CGTX Stock Latest News

Cognition Therapeutics presents preclinical data on zervimesine at ARVO
The FlyCognition Therapeutics presents preclinical data on zervimesine at ARVO
4d ago
CGTX
Cognition Therapeutics Reports Q1 2025 Financials and Progress
PremiumCompany Announcements
Cognition Therapeutics Reports Q1 2025 Financials and Progress
4d ago
CGTX
Cognition Therapeutics reports results from Phase 2 COG2201 trial
PremiumThe Fly
Cognition Therapeutics reports results from Phase 2 COG2201 trial
5d ago
CGTX
Cognition Therapeutics Announces Positive Phase 2 Trial Results
PremiumCompany Announcements
Cognition Therapeutics Announces Positive Phase 2 Trial Results
5d ago
8K
CGTX
Cognition Therapeutics reports Q1 EPS (14c), consensus (12c)
PremiumThe Fly
Cognition Therapeutics reports Q1 EPS (14c), consensus (12c)
6d ago
CGTX
Cognition Therapeutics sees cash runway into 4Q25
PremiumThe FlyCognition Therapeutics sees cash runway into 4Q25
6d ago
CGTX
Cognition Therapeutics presents results at AD/PD 2025 on CT1812
Premium
The Fly
Cognition Therapeutics presents results at AD/PD 2025 on CT1812
1M ago
CGTX
Buy Recommendation for Cognition Therapeutics: Promising Phase 2 Results and Strategic Focus on Alzheimer’s and Dementia Indications
Premium
Ratings
Buy Recommendation for Cognition Therapeutics: Promising Phase 2 Results and Strategic Focus on Alzheimer’s and Dementia Indications
2M ago
CGTX
Cognition Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe Fly
Cognition Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
2M ago
CGTX
Cognition Therapeutics Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Cognition Therapeutics Earnings Call: Progress Amid Challenges
2M ago
CGTX
Cognition Therapeutics price target lowered to $8 from $11 at Chardan
PremiumThe Fly
Cognition Therapeutics price target lowered to $8 from $11 at Chardan
2M ago
CGTX
Cognition Therapeutics Advances Alzheimer’s and DLB Trials
PremiumCompany Announcements
Cognition Therapeutics Advances Alzheimer’s and DLB Trials
2M ago
CGTX
Cognition Therapeutics reports FY24 EPS (86c), consensus (74c)
PremiumThe FlyCognition Therapeutics reports FY24 EPS (86c), consensus (74c)
2M ago
CGTX
Is CGTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is CGTX a Buy, Before Earnings?
2M ago
CGTX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
IPA
PBM
Cognition Therapeutics publishes research on zervimesine in dry AMD
PremiumThe Fly
Cognition Therapeutics publishes research on zervimesine in dry AMD
3M ago
CGTX
Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study
PremiumThe Fly
Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study
3M ago
CGTX
Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit
PremiumThe Fly
Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit
3M ago
CGTX
Cognition announces publication of zervimesine manufacturing process
PremiumThe Fly
Cognition announces publication of zervimesine manufacturing process
3M ago
CGTX
Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley
PremiumThe FlyCognition Therapeutics price target raised to $2 from $1.50 at B. Riley
3M ago
CGTX
Cognition announces Phase 2 ‘SHIMMER’ study to be presented at ILBDC
Premium
The Fly
Cognition announces Phase 2 ‘SHIMMER’ study to be presented at ILBDC
3M ago
CGTX
Cognition Therapeutics Shows Promising Phase 2 Study Results
Premium
Company Announcements
Cognition Therapeutics Shows Promising Phase 2 Study Results
4M ago
8K
CGTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >